Cervical Lymphadenopathy
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients with cystic lateral neck lump (More than 10 mm) with no evidence of primary tumor who underwent cervical lymph node excisional biopsy between April 2021 and May 2023 were included.
Exclusion criteria
Exclusion criteria: The study excluded patients without preoperative US or FNAC evaluations or documentation, as well as those with infectious etiologies, evidence of a primary tumor at clinical examination with endoscopy, past head and neck oncological surgery, neoadjuvant radiotherapy, solid aspect of the neck mass, and patients who did not undergo excisional biopsy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Investigate the diagnostic value of FNAC and US findings in comparison with postoperative histopathological diagnoses of cervical lymph node excisional biopsy | — |
Secondary
| Measure | Time frame |
|---|---|
| Predictive diagnostic radiologic tests | — |
Countries
Asia(except Japan)
Contacts
Ibb University Department of Surgery